Outcome after combined modality treatment for uterine papillary serous carcinoma (UPSC): A Rare Cancer Network (RCN) Multicenter Study.

被引：0
|
作者：
Goldberg, H
Abdah-Bortniak, R
Shteiner, M
Gilboa, Y
Freixa, SV
Marin, S
Mendez, A
Azria, D
Poortmans, P
Kuten, A
机构：
[1] Rambam Med Ctr, Haifa, Israel
[2] Lin Med Ctr, Haifa, Israel
[3] Rabin Med Ctr, Petah Tiqwa, Israel
[4] Hosp Llobregat, Inst Catala Oncol, Lhospitalet De Llobregat, Spain
[5] CRLC Val Aurelle, Montpellier, France
[6] Bernard Verbeeten Inst, La Tilburg, Netherlands
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：473S / 473S
页数：1
相关论文
共 50 条
  • [1] Outcome after combined modality treatment for uterine papillary serous carcinoma: a rare cancer network (RCN) multicenter study
    Goldberg, H.
    Miller, R.
    Abdah-Bortnyak, R.
    Shteiner, M.
    Gilboa, Y.
    Villa Freixa, S.
    Mendez, A.
    Azria, D.
    Poortmans, P.
    Kuten, A.
    EJC SUPPLEMENTS, 2005, 3 (02): : 264 - 265
  • [2] Outcome after combined modality treatment for uterine papillary serous carcinoma:: A study by the Rare Cancer Network (RCN)
    Goldberg, Hadassah
    Miller, Robert C.
    Abdah-Bortnyak, Roxolyana
    Steiner, Mariana
    Yildiz, Ferah
    Meirovitz, Amichav
    Villa, Salvador
    Poortmans, Philip M. P.
    Azria, David
    Zidan, Jamal
    Ozsahin, Mahmut
    Abacioglu, Ufuk
    Gold, Douglas G.
    Amit, Amnon
    Lavie, Ofer
    Atahan, I. Lale
    Kuten, Abraham
    GYNECOLOGIC ONCOLOGY, 2008, 108 (02) : 298 - 305
  • [3] UTERINE PAPILLARY SEROUS CARCINOMA (UPSC) - A CLINICOPATHOLOGICAL STUDY OF 30 CASES
    KATO, DT
    FERRY, JA
    GOODMAN, A
    SULLINGER, J
    SCULLY, RE
    GOFF, BA
    FULLER, AF
    RICE, LW
    GYNECOLOGIC ONCOLOGY, 1995, 59 (03) : 384 - 389
  • [4] INTRAVENOUS CISPLATIN, DOXORUBICIN, AND CYCLOPHOSPHAMIDE IN THE TREATMENT OF UTERINE PAPILLARY SEROUS CARCINOMA (UPSC)
    PRICE, FV
    CHAMBERS, SK
    CARCANGIU, ML
    KOHORN, EI
    SCHWARTZ, PE
    CHAMBERS, JT
    GYNECOLOGIC ONCOLOGY, 1993, 51 (03) : 383 - 389
  • [5] The treatment of uterine papillary serous carcinoma (UPSC): are we doing the right thing?
    Tay, EH
    Ward, BG
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 1999, 9 (06) : 463 - 469
  • [6] ECT2: A Molecular Target for the Treatment of Uterine Papillary Serous Carcinoma (UPSC)
    Mach, Claire M.
    Magliaro, Thomas J., Jr.
    Anderson, Matthew L.
    REPRODUCTIVE SCIENCES, 2014, 21 (03) : 120A - 121A
  • [7] An updated clinicopathologic study of early-stage uterine papillary serous carcinoma (UPSC)
    Fader, Amanda Nickles
    Starks, David
    Gehrig, Paola A.
    Secord, Angeles Alvarez
    Frasure, Heidi E.
    O'Malley, David M.
    Tuller, Erin R.
    Rose, Peter G.
    Havrilesky, Laura J.
    Moore, Kathleen N.
    Huh, Warner K.
    Axtell, Allison E.
    Kelley, Joseph L.
    Zanotti, Kristine M.
    GYNECOLOGIC ONCOLOGY, 2009, 115 (02) : 244 - 248
  • [8] Combined modality therapy in the adjuvant treatment of uterine serous carcinoma
    Block, Alec M.
    Small, William, Jr.
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2016, 27 (02)
  • [9] Non-invasive uterine papillary serous carcinoma (UPSC): A study of 11 cases.
    Carcangiu, ML
    Chambers, J
    LABORATORY INVESTIGATION, 1996, 74 (01) : 505 - 505
  • [10] Combined Modality Therapy Improves Survival in Uterine Papillary Serous Carcinoma with Omental Involvement
    Lee, L. J.
    Tanaka, C.
    Viswanathan, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S479 - S479
12345